Michael Julian Humphreys - 20 Oct 2023 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
Director
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Issuer symbol
TGAN
Transactions as of
20 Oct 2023
Transactions value $
$0
Form type
4
Filing time
24 Oct 2023, 16:13:46 UTC
Previous filing
13 Oct 2023
Next filing
23 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGAN Common Stock Award $0 +2.81K +3.29% $0.00 88.2K 20 Oct 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a Restricted Stock Unit ("RSU") that was fully vested as of the grant date. The RSUs were automatically granted to the Reporting Person pursuant to the Issuer's Outside Director Compensation Policy in lieu of cash fees for service during the quarter ended September 30, 2023.